Hepatitis E vaccine: Why wait?

The Lancet

Volumn 376, Issue 9744, 2010, Pages 845-

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS VACCINE; RECOMBINANT VACCINE;

ADOLESCENT; ADULT; AGED; CHINA; DRUG INDUSTRY; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MORTALITY; NEPAL; ORGANIZATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VERTICAL TRANSMISSION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHINA; CONGRESSES AS TOPIC; DRUG INDUSTRY; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MIDDLE AGED; NEPAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VACCINES, SYNTHETIC; VIRAL HEPATITIS VACCINES; YOUNG ADULT;

EID: 77956593396     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61393-1     Document Type: Editorial

References (4)

1. For more on the International Symposium on Hepatitis E see http://www.ivi.org/popup/hepE-symposium/default.asp
2. For Shrestha and colleagues' paper see N Engl J Med 2007; 356: 895-903
3. For a review of hepatitis E see Lancet Infect Dis 2008; 8: 698-709
4. For more on hepatitis E and pregnancy see Aggarwal R. Indian J Gastroenterol 2007; 26: 3-5